<VariationArchive VariationID="3254981" VariationName="NM_022552.5(DNMT3A):c.1367del (p.Lys456fs)" VariationType="Deletion" Accession="VCV003254981" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-07-29" DateCreated="2024-07-23" MostRecentSubmission="2024-07-23">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="3413755" VariationID="3254981">
      <GeneList>
        <Gene Symbol="DNMT3A" FullName="DNA methyltransferase 3 alpha" GeneID="1788" HGNC_ID="HGNC:2978" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2p23.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="25227874" stop="25342590" display_start="25227874" display_stop="25342590" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="25455829" stop="25565458" display_start="25455829" display_stop="25565458" Strand="-" />
          </Location>
          <OMIM>602769</OMIM>
          <Haploinsufficiency last_evaluated="2018-04-29" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=DNMT3A">Little evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2018-04-29" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=DNMT3A">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_022552.5(DNMT3A):c.1367del (p.Lys456fs)</Name>
      <CanonicalSPDI>NC_000002.12:25246221:TTTTT:TTTT</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>2p23.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="25246222" stop="25246222" display_start="25246222" display_stop="25246222" variantLength="1" positionVCF="25246221" referenceAlleleVCF="CT" alternateAlleleVCF="C" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="25469091" stop="25469091" display_start="25469091" display_stop="25469091" variantLength="1" positionVCF="25469090" referenceAlleleVCF="CT" alternateAlleleVCF="C" />
      </Location>
      <ProteinChange>K233fs</ProteinChange>
      <ProteinChange>K267fs</ProteinChange>
      <ProteinChange>K304fs</ProteinChange>
      <ProteinChange>K456fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.25246226del" Assembly="GRCh38">
            <Expression>NC_000002.12:g.25246226del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_029465.2" sequenceAccession="NG_029465" sequenceVersion="2" change="g.101369del">
            <Expression>NG_029465.2:g.101369del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_022552.5" sequenceAccession="NM_022552" sequenceVersion="5" change="c.1367del" MANESelect="true">
            <Expression>NM_022552.5:c.1367del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_072046.2" sequenceAccession="NP_072046" sequenceVersion="2" change="p.Lys456fs">
            <Expression>NP_072046.2:p.Lys456fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_153759.3" sequenceAccession="NM_153759" sequenceVersion="3" change="c.800del">
            <Expression>NM_153759.3:c.800del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_715640.2" sequenceAccession="NP_715640" sequenceVersion="2" change="p.Lys267fs">
            <Expression>NP_715640.2:p.Lys267fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_175629.2" sequenceAccession="NM_175629" sequenceVersion="2" change="c.1367del">
            <Expression>NM_175629.2:c.1367del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_783328.1" sequenceAccession="NP_783328" sequenceVersion="1" change="p.Lys456fs">
            <Expression>NP_783328.1:p.Lys456fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_135490.2" sequenceAccession="NR_135490" sequenceVersion="2" change="n.1598del">
            <Expression>NR_135490.2:n.1598del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_022552.4" sequenceAccession="NM_022552" sequenceVersion="4" change="c.1367delA">
            <Expression>NM_022552.4:c.1367delA</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_459" sequenceAccession="LRG_459">
            <Expression>LRG_459:g.101369del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_459t1" sequenceAccession="LRG_459t1">
            <Expression>LRG_459t1:c.1363del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_459p1" sequenceAccession="LRG_459p1" change="p.Lys456Serfs">
            <Expression>LRG_459p1:p.Lys456Serfs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_459t2" sequenceAccession="LRG_459t2">
            <Expression>LRG_459t2:c.800del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_459p2" sequenceAccession="LRG_459p2" change="p.Lys267fs">
            <Expression>LRG_459p2:p.Lys267fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_459t4" sequenceAccession="LRG_459t4">
            <Expression>LRG_459t4:c.1367del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_459p4" sequenceAccession="LRG_459p4" change="p.Lys456fs">
            <Expression>LRG_459p4:p.Lys456fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001320893.1" sequenceAccession="NM_001320893" sequenceVersion="1" change="c.911del">
            <Expression>NM_001320893.1:c.911del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001307822.1" sequenceAccession="NP_001307822" sequenceVersion="1" change="p.Lys304fs">
            <Expression>NP_001307822.1:p.Lys304fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001375819.1" sequenceAccession="NM_001375819" sequenceVersion="1" change="c.698del">
            <Expression>NM_001375819.1:c.698del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001362748.1" sequenceAccession="NP_001362748" sequenceVersion="1" change="p.Lys233fs">
            <Expression>NP_001362748.1:p.Lys233fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.25469095del" Assembly="GRCh37">
            <Expression>NC_000002.11:g.25469095del</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_022552.5(DNMT3A):c.1367del (p.Lys456fs) AND Tatton-Brown-Rahman overgrowth syndrome" Accession="RCV004595164" Version="1">
        <ClassifiedConditionList TraitSetID="16415">
          <ClassifiedCondition DB="MedGen" ID="C4014545">Tatton-Brown-Rahman overgrowth syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-12-21" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-12-21" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2024-07-23" MostRecentSubmission="2024-07-23">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">30478443</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="16415" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="21246" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Tall stature-intellectual disability-facial dysmorphism syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Tatton-Brown-Rahman overgrowth syndrome</ElementValue>
                <XRef ID="MONDO:0014382" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Tatton-Brown-rahman syndrome</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">TBRS</ElementValue>
                <XRef Type="MIM" ID="615879" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17674" />
                <XRef ID="17674" DB="Office of Rare Diseases" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">Tatton-Brown-Rahman syndrome (TBRS) is an overgrowth / intellectual disability syndrome characterized by length/height and/or head circumference ≥2 SD above the mean for age and sex, obesity / increased weight, intellectual disability that ranges from mild to severe, joint hypermobility, hypotonia, behavioral/psychiatric issues, kyphoscoliosis, and seizures. Individuals with TBRS have subtle dysmorphic features, including a round face with coarse features, thick horizontal low-set eyebrows, narrow (as measured vertically) palpebral fissures, and prominent upper central incisors. The facial gestalt is most easily recognizable in the teenage years. TBRS may be associated with an increased risk of developing acute myeloid leukemia. There are less clear associations with aortic root dilatation and increased risk of other hematologic and solid tumors.</Attribute>
                <XRef ID="NBK581652" DB="GeneReviews" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">35771960</ID>
                <ID Source="BookShelf">NBK581652</ID>
              </Citation>
              <XRef ID="404443" DB="Orphanet" />
              <XRef ID="C4014545" DB="MedGen" />
              <XRef ID="MONDO:0014382" DB="MONDO" />
              <XRef Type="MIM" ID="615879" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="9874423" SubmissionDate="2024-07-18" DateLastUpdated="2024-07-23" DateCreated="2024-07-23">
        <ClinVarSubmissionID localKey="vcgs/unit_1/hg38_NM_022552_4_DNMT3A_c_1367delA" localKeyIsSubmitted="1" />
        <ClinVarAccession Accession="SCV005085917" DateUpdated="2024-07-23" DateCreated="2024-07-23" Type="SCV" Version="1" SubmitterName="Victorian Clinical Genetics Services, Murdoch Childrens Research Institute" OrgID="500104" OrganizationCategory="laboratory" OrgAbbreviation="VCGS" />
        <AdditionalSubmitters>
          <SubmitterDescription OrgID="508197" SubmitterName="Shariant Australia, Australian Genomics" Type="behalf" OrganizationCategory="consortium" />
        </AdditionalSubmitters>
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-12-21">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">30478443</ID>
          </Citation>
          <Comment>Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0103 - Loss of function and gain of function are known mechanisms of disease in this gene, and are associated with disease. Loss of function has been associated with Tatton-Brown-Rahman syndrome (MIM#615879), while gain of function has been associated with Heyn-Sproul-Jackson syndrome (MIM#618724) and demonstrated for two missense variants (PMID: 30478443). (I) 0107 - This gene is associated with autosomal dominant disease. (I) 0201 - Variant is predicted to cause nonsense-mediated decay (NMD) and loss of protein (premature termination codon is located at least 54 nucleotides upstream of the final exon-exon junction). (SP) 0251 - This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0701 - Other NMD-predicted variants comparable to the one identified in this case have very strong previous evidence for pathogenicity (DECIPHER). (SP) 0807 - This variant has no previous evidence of pathogenicity. (I) 0905 - No published segregation evidence has been identified for this variant. (I) 1007 - No published functional evidence has been identified for this variant. (I) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="DNMT3A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="SubmitterVariantId">ALLELE_23471</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_022552.4:c.1367delA</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="615879" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>submission_45</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="9874423" TraitType="Disease" MappingType="XRef" MappingValue="615879" MappingRef="OMIM">
        <MedGen CUI="C4014545" Name="Tatton-Brown-Rahman overgrowth syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

